Company: CYTK
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013167
Chunk: 99

Company: CYTOKINETICS INC
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 99
---
 Annual Equity Grants to Non-Employee Directors” above as follows: Ms. Bhanji - $0.1 million; Mr. Costa - $0.1 million; Dr. Henderson $0.2 million; Dr. Kaye - $0.1 million; Ms. Parhsall - $0.1 million; Mr. Smith - $0.1 million; Dr. Wierenga - $0.2 million; and Ms. Wysenski $0.1 million. As of December 31, 2024, the aggregate number of stock options held by our non-employee directors at such time were as follows: Ms. Bhanji – 68,266; Mr. Costa – 72,333; Dr. Harrington – 54,377; Dr. Henderson – 205,649; Dr. Kaye – 150,646; Ms. Parshall – 36,015; Mr. Smith – 17,500; Dr. Wierenga – 167,387; and Ms. Wysenski – 68,266. |

| (3) | Automatic grants of RSUs to non-employee directors were granted at the time of the 2024 annual meeting of stockholders (May 15,2024). The amounts in the table reflect the grant date fair value of the RSU awards calculated in accordance with Topic 718. Assumptions used for the valuation of these grants are set forth in Note 8 of our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024. As of December 31, 2024, the aggregate number of unvested RSUs held by our non-employee directors at December 31, 2024 was 3,636 per director. |

We reimburse our non-employee directors for out-of-pocket expenses incurred in connection with service on our Board of Directors.

| Cytokinetics, Inc.|2025 Proxy Statement |     | 69 |

TABLE OF CONTENTS Delinquent Section 16(a) Reports On March 4, 2024, 3 of our executive officers (Mr. Blum, Dr. Malik and Mr. Callos) had RSUs withheld by the Company for taxes in connection with the vesting of RSUs. Form 4s were filed late for these withholding transactions on March 7, 2024 due to an internal reporting error. In addition, Mr. Bl